[PDF] Top 20 Cooperación universidad-empresa : un modelo de antecedentes y consecuencias
Has 10000 "Cooperación universidad-empresa : un modelo de antecedentes y consecuencias" found on our website. Below are the top 20 most common "Cooperación universidad-empresa : un modelo de antecedentes y consecuencias".
Detecting Circulating Tumor Cells: Current Challenges and New Trends
... tional challenges, as well as opportunities, are ex- pected to ...and tumor cell separation; 2) cell staining by antibodies or gene probing by DNA probes; and 3) CTC detection (Fig- ure ... See full document
80
Circulating Tumor Cells as a Tool for Assessing Tumor Heterogeneity
... 4 new driver mutations in renal cell carcin- oma stem cells using WES that constitute important prognostic factors and therapeutic targets ...each tumor related to different diagnoses, prognoses and ... See full document
33
Emerging concepts in liquid biopsies
... of circulating free DNA (cfDNA) found in the plasma component of blood to evaluate the current status of the cancer ...as circulating tumor cells (CTCs) or exosomes, have been ... See full document
24
Head and neck cancer: searching for genomic and epigenetic biomarkers in body fluids – the state of art
... structural genomic alterations and mutational spectrum of HNSCC. Alterations in almost all chromosomes have been described in these tumors, being some chromo- somal regions and genes reported in the literature as more ... See full document
5
<p>The Frequency of Circulating Tumour Cells and the Correlation with the Clinical Response to Standard Chemoradiotherapy in Locally Advanced Nasopharyngeal Carcinoma: A Prospective Study</p>
... All patients underwent two cycles of induced chemother- apy with raltitrexed and cisplatin, 13,14 followed by the same regimen concurrent with radiotherapy (two cycles of con- current combination chemotherapy plus ... See full document
73
Clinical relevance and current challenges of research on disseminating tumor cells in cancer patients
... CD45-negative cells are counted by laser scanning cytometry ...a new sample preparation technology, the MagSweeper – an automated immunomagnetic separation technology ... See full document
5
Association of a novel circulating tumor DNA next generating sequencing platform with circulating tumor cells (CTCs) and CTC clusters in metastatic breast cancer
... In MBC, ctDNA genomic alterations have been stud- ied to understand the genetic heterogeneity of tumor re- sistance. Specifically, markers of endocrine resistance emerge in response to the selective pressures of ... See full document
15
Clinical applications of liquid biopsy as prognostic and predictive biomarkers in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA
... on tumor-specific genetic or epigenetic alterations, such as point mutations, copy num- ber variations (CNVs), chromosomal rearrangements, and DNA methylation patterns and offers a unique opportun- ity for ... See full document
12
Circulating tumor cells and DNA as liquid biopsies
... end, circulating tumor cells (CTCs) or circulating tumor DNA (ctDNA) shed from primary and metastatic cancers may allow the non-invasive analysis of the evolution of tumor ... See full document
31
Exploring Markov modeling approaches for the health economic assessment of circulating tumor cells in the management of metastatic prostate cancer patients
... Approximately 900 novel cancer drugs are currently under development by biopharma- ceutical researchers [57]. These novel drug- based therapies are evolving fast. Also known as ‘target drugs’, these drugs target specific ... See full document
88
Nanotechnology for the detection and kill of circulating tumor cells
... Circulating tumor cells (CTCs) represent a surrogate biomarker of hematogenous metastases and thus could be considered as a ‘ liquid biopsy ’ which reveals metastasis in ... See full document
8
The emerging roles of NGS-based liquid biopsy in non-small cell lung cancer
... in detecting EGFR exon 19 deletion, exon 21 L858R mutation, and exon 20 T790M ...from current largest data enrolling 229 advanced NSCLC patients with matched NGS-based ctDNA and tissue tests demonstrated ... See full document
94
Genomics and epidemiology for gastric adenocarcinomas
... Few studies, involving small patient groups, have evalu- ated the detection and the qualitative analysis of CTCs in GACs. Using the CellSearch® system authors reported the detection of CTCs in 14% of patients with ... See full document
10
Stemness Gene Profiles of Circulating Tumor Cells
... stem cells by inhibiting expression of hu- man chorionic gonadotropin, a placental marker of embryonic stem ...stem cells, which correlates to poor clinical outcomes ... See full document
78
Tumorigenic potential of circulating prostate tumor cells
... initiating new sites of tumor ...have tumor cells in the bone marrow prior to surgery ...with tumor cells in bone marrow did not have biochemical recurrence after surgery, ... See full document
8
Clinical relevance and biology of circulating tumor cells
... of circulating tumor cells EMT and stemness of tumor cells seem to be linked mechanistically ...in circulating tumor cells of breast cancer ...of circulating ... See full document
13
Excerpts from the 1st international NTNU symposium on current and future clinical biomarkers of cancer: innovation and implementation, June 16th and 17th 2016, Trondheim, Norway
... Early diagnosis gets a new meaning when tumor-spe- cific changes can be seen in the blood several years before clinical tumor is evident. Early pre-diagnostic tests may also change prognosis ... See full document
5
Technical challenges in the isolation and analysis of circulating tumor cells
... blood cells of a patient sample, nucleated cells are plated on positively-charged proprietary adhesion slides, subjected to immunofluorescence staining and analyzed by special fluorescent scanners ...occult ... See full document
192
Stem cell technology in breast cancer: current status and potential applications
... normal cells by specific classes of antibiotics results from the “endosymbiotic theory of mitochondrial evolution” and in normal cells it exerts mild side effects, which are well tolerated in most ...cancer ... See full document
6
Gold Nanoparticle Based Platforms for Circulating Cancer Marker Detection
... formed on the Au NP surface may differ between cancerous and noncancerous human blood. Therefore, cancer-specific antigens should be in the protein corona layer that can be probed with antibodies. Rabbit anti-human IgG ... See full document
47
Related subjects